Jue Andrea
Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.
Semin Ophthalmol. 2009 Mar-Apr;24(2):122-5. doi: 10.1080/08820530902801015.
The use of bevacizumab for the treatment of proliferative diabetic retinopathy, neovascular glaucoma, neovascular age related macular degeneration, and cystoid macular edema has been extensively reported upon. From the published case reports available, bevacizumab may be a useful adjunct to the trabeculectomy procedure.
贝伐单抗用于治疗增殖性糖尿病视网膜病变、新生血管性青光眼、年龄相关性黄斑变性和黄斑囊样水肿已被广泛报道。从现有的已发表病例报告来看，贝伐单抗可能是小梁切除术的一种有用辅助药物。
